Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer

Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer

Item
http://www.wikidata.org/entity/Q33983656
Mechanisms underlying skin disorders induced by EGFR inhibitorsBiological agents in gastrointestinal cancers: adverse effects and their management.Antiepidermal growth factor receptor monoclonal antibodies: applications in colorectal cancer.Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case reviewEpidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer.Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence.Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational StudyEfficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.Kinase-targeted cancer therapies: progress, challenges and future directions.Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling.
P2860

Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer

Item
http://www.wikidata.org/entity/Q33983656
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adverse events associated with ...... f metastatic colorectal cancer
@ast
Adverse events associated with ...... f metastatic colorectal cancer
@en
type
label
Adverse events associated with ...... f metastatic colorectal cancer
@ast
Adverse events associated with ...... f metastatic colorectal cancer
@en
prefLabel
Adverse events associated with ...... f metastatic colorectal cancer
@ast
Adverse events associated with ...... f metastatic colorectal cancer
@en
P1433
P1476
P2093
P2860
P304
P31
P478
P577
P698
P921
P932
P1433
P1476
Adverse events associated with ...... f metastatic colorectal cancer
@en
P2093
P2860
P304
P31
P478
P577
P698
P921
P932